CFZ monotherapy exhibited moderate therapeutic efficacy against MM, and ZMYND8 overexpression significantly suppressed tumor proliferation and augmented the efficacy of CFZ in MM (Figure 7L–N). This evidence concerns the gene ZMYND8 and neoplasm.